A petition that called for the decriminalization of psychedelics garnered about 15,000 signatures surpassing the required 500 signatures and will be read formally in the House of Commons after sessions resume on September 23. It talks about the different uses of entheogen plants and fungi as well as the substances’ therapeutic potential. After it’s been introduced, the government has 45 days to put out a response.
The MP Paul Manly of the Green Party who sponsored the petition revealed bigger plans for the bill, saying that he’d continue his support while pushing for decriminalization of possession of all drugs that are presently illicit.
He also highlighted the need for a serious discussion on decriminalization. He admitted to being in favor of full legalization, that way the drugs would be regulated properly. This, he states, is the government’s role seeing as regulating the drugs through the Controlled Drugs and Substances Act and criminalizing efforts have yielded no positive returns.
In addition to calling for decriminalization, the petition also stated that legislators should revise government drug laws to exempt and distinguish these drugs when utilized for curative purposes as well as medical care, solitary spiritual growth, healing ceremonies and self-development.
The 14,910 signatures it gathered are among the highest number an official government petition has collected in Parliament.
The individual who introduced the petition, Trevor Millar, serves on MAPS Canada as the board chair and also as the Canadian Psychedelic Associations’ Executive director. He states that the petition is meant to serve as an educational vehicle.
In the United States, movements to legitimize psychedelics are beginning to grow.
For instance, in May 2019, Denver was the first United States city with local ballot measure approval to decriminalize psilocybin, after which administrators in Oakland also decriminalized possession of fungi and plant-based psychedelics. In Santa Cruz, the City Council voted to make implementation of laws against psychedelics the city’s lowest concern in January of this year.
The secretary of state for Oregon also verified last month that on the November ballot, steps to legalize psilocybin therapy and legitimize possession of all drugs and the expansion of treatment services will be present.
On Thursday, MAPS reported that it had raised donations worth $30 million, some from significantly well-known business leaders. The donations will enable completion of a study on utilizing MDMA to remedy PTSD.
Entities like Field Trip Psychedelics are probably banking on the increasing public support to carry the industry forward, especially on the medicinal front.
About PsychedelicNewsWire
PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.
To receive instant SMS alerts, text “Groovy” to 888-902-4192 (U.S. Mobile Phones Only)
For more information please visit https://www.psychedelicnewswire.com
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.psychedelicnewswire.com/Disclaimer
Do you have questions or are you interested in working with PNW? Ask our Editor
PsychedelicNewsWire (PNW)
San Francisco, California
www.psychedelicnewswire.com
415.949.5050 Office
Editor@PsychedelicWire.com
PsychedelicNewsWire is part of the InvestorBrandNetwork.
